Validated using a knockout cell line
Recombinant
RabMAb

Anti-CKII alpha antibody [EP1963Y] (ab76040)

Publishing research using ab76040? Please let us know so that we can cite the reference in this datasheet.

ab76040 has been referenced in 2 publications.

  • Cannon C  et al. Therapeutic targeting of protein kinase CK2 gene expression in feline oral squamous cell carcinoma - a naturally occurring large animal model of head and neck cancer. Hum Gene Ther Clin Dev N/A:N/A (2017). PubMed: 28335614
  • Manni S  et al. Protein Kinase CK2 Inhibition Down Modulates the NF-?B and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells. PLoS One 8:e75280 (2013). WB, IHC-P ; Human . PubMed: 24086494

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up